Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

FDA Drug Recalls

11,818 recalls · Class II, newest first

Class II · Moderate risk

Nystatin Oral Suspension

Subpotent drug: Out of specification for assay at the 15-month test interval.

Terminated Wrong potency / content PAI Holdings, LLC. dba Pharmaceutical Associates Inc NDC 0121-0810-16 D-1494-2020
Class II · Moderate risk

Heparin Sodium 5

Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.

Terminated Wrong potency / content SCA Pharmaceuticals NDC 70004-0650-46 D-1495-2020
Class II · Moderate risk

Herbacil

CGMP Deviations: products were recalled because they were manufactured in the same facility as the product found to contain methanol.

Terminated Chemical / undeclared Broncolin, S.A. de C.V. D-1577-2020
Class II · Moderate risk

Phentermine HCL Blue Speckled tablets

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 10702-0025-10 D-1532-2020
Class II · Moderate risk

Phentermine HCL Blue/White Capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 10702-0029-10 D-1529-2020
Class II · Moderate risk

Phentermine HCL Blue/Clear capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 10702-0028-10 D-1528-2020
Class II · Moderate risk

Phentermine HCL Yellow Caps 30mg

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 51224-0202-70 D-1527-2020
Class II · Moderate risk

Phentermine HCL GrayYellow capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 51224-0203-70 D-1526-2020
Class II · Moderate risk

Phentermine 15mg grey/Yellow Capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 11534-0157-03 D-1525-2020
Class II · Moderate risk

Phentermine HCL Gray/Yellow capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 10702-0026-10 D-1524-2020
Class II · Moderate risk

Phendimetrazine Brown/Clear Capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 69543-0409-11 D-1523-2020
Class II · Moderate risk

Phendimetrazine Yellow Tabs 35mg

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 69543-0410-11 D-1522-2020

Recalls by year